US FDA staff raises ... use of the drug for the first time. EU regulator backs use of Pfizer's gene therapy for rare bleeding ...
This summary highlights key events in the health sector, including the mixed results of Gilead's Trodelvy in cancer trials, ...
EU publishes its first list ... The U.S. Food and Drug Administration (FDA) on Friday approved two gene therapies for sickle ...